JENNIFER DAWE: Open Payments
NPI 1164720090 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,077 in 38 payments from 19 companies in 2025. Trend: 2023 $336 · 2024 $741 · 2025 $1,077
Food & beverage: $997Education: $80
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $193 |
| AstraZeneca Pharmaceuticals LP | 5 | $144 |
| Daiichi Sankyo Inc. | 5 | $129 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Gilead Sciences, Inc. | 3 | $75 |
| ARRAY BIOPHARMA INC | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $44 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $42 |
| Blueprint Medicines Corporation | 1 | $38 |
Products named: SARCLISA, ENHERTU, DATROWAY, AYVAKIT, Trodelvy, NERLYNX, BRAFTOVI, LIBTAYO.
Industry payments across GA — which companies pay providers there.
